nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—SLC22A7—Rifampicin—leprosy	0.494	1	CbGbCtD
Minocycline—CASP3—appendage—leprosy	0.0146	0.0701	CbGeAlD
Minocycline—IL1B—hindlimb—leprosy	0.0136	0.0653	CbGeAlD
Minocycline—CASP3—skin epidermis—leprosy	0.0122	0.0583	CbGeAlD
Minocycline—IL1B—appendage—leprosy	0.0117	0.056	CbGeAlD
Minocycline—MMP9—hindlimb—leprosy	0.0113	0.0544	CbGeAlD
Minocycline—CASP3—nerve—leprosy	0.0104	0.0497	CbGeAlD
Minocycline—MMP9—appendage—leprosy	0.00972	0.0467	CbGeAlD
Minocycline—IL1B—skin epidermis—leprosy	0.00971	0.0466	CbGeAlD
Minocycline—CYCS—blood vessel—leprosy	0.00949	0.0455	CbGeAlD
Minocycline—CASP1—NOD1/2 Signaling Pathway—CYLD—leprosy	0.00879	0.0304	CbGpPWpGaD
Minocycline—IL1B—IL23-mediated signaling events—IL23R—leprosy	0.0087	0.0301	CbGpPWpGaD
Minocycline—IL1B—IL1 and megakaryotyces in obesity—TLR1—leprosy	0.00853	0.0295	CbGpPWpGaD
Minocycline—CASP3—blood vessel—leprosy	0.00813	0.039	CbGeAlD
Minocycline—MMP9—skin epidermis—leprosy	0.00809	0.0388	CbGeAlD
Minocycline—MMP9—IL1 and megakaryotyces in obesity—TLR1—leprosy	0.00654	0.0226	CbGpPWpGaD
Minocycline—IL1B—blood vessel—leprosy	0.0065	0.0312	CbGeAlD
Minocycline—CASP1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CYLD—leprosy	0.00599	0.0208	CbGpPWpGaD
Minocycline—CYCS—Sulfisoxazole—Dapsone—leprosy	0.00587	0.656	CbGdCrCtD
Minocycline—CASP1—NOD1/2 Signaling Pathway—RIPK2—leprosy	0.00566	0.0196	CbGpPWpGaD
Minocycline—CYCS—Parkinsons Disease Pathway—PARK2—leprosy	0.00565	0.0196	CbGpPWpGaD
Minocycline—CASP1—Apoptosis—LTA—leprosy	0.00562	0.0194	CbGpPWpGaD
Minocycline—MMP9—blood vessel—leprosy	0.00541	0.026	CbGeAlD
Minocycline—CASP1—NOD1/2 Signaling Pathway—NOD2—leprosy	0.00513	0.0178	CbGpPWpGaD
Minocycline—CYCS—eye—leprosy	0.00505	0.0242	CbGeAlD
Minocycline—IL1B—Senescence and Autophagy in Cancer—TNFSF15—leprosy	0.00498	0.0173	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—LTA—leprosy	0.00481	0.0166	CbGpPWpGaD
Minocycline—CASP1—skin of body—leprosy	0.00457	0.0219	CbGeAlD
Minocycline—CASP3—Parkinsons Disease Pathway—PARK2—leprosy	0.00456	0.0158	CbGpPWpGaD
Minocycline—CASP1—NOD pathway—RIPK2—leprosy	0.00453	0.0157	CbGpPWpGaD
Minocycline—CYCS—skin of body—leprosy	0.0044	0.0211	CbGeAlD
Minocycline—IL1B—IL1 and megakaryotyces in obesity—TLR2—leprosy	0.00434	0.015	CbGpPWpGaD
Minocycline—CASP3—eye—leprosy	0.00433	0.0208	CbGeAlD
Minocycline—CASP1—NOD pathway—NOD2—leprosy	0.0041	0.0142	CbGpPWpGaD
Minocycline—CASP1—Parkin-Ubiquitin Proteasomal System pathway—PARK2—leprosy	0.00405	0.014	CbGpPWpGaD
Minocycline—CYCS—Respiratory electron transport—SDHD—leprosy	0.00391	0.0135	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—LTA—leprosy	0.00388	0.0134	CbGpPWpGaD
Minocycline—CASP1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—RIPK2—leprosy	0.00386	0.0134	CbGpPWpGaD
Minocycline—CYCS—FAS pathway and Stress induction of HSP regulation—RIPK2—leprosy	0.0038	0.0132	CbGpPWpGaD
Minocycline—CASP3—skin of body—leprosy	0.00376	0.0181	CbGeAlD
Minocycline—CASP1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NOD2—leprosy	0.0035	0.0121	CbGpPWpGaD
Minocycline—CASP1—tendon—leprosy	0.00348	0.0167	CbGeAlD
Minocycline—IL1B—eye—leprosy	0.00346	0.0166	CbGeAlD
Minocycline—MMP9—IL1 and megakaryotyces in obesity—TLR2—leprosy	0.00333	0.0115	CbGpPWpGaD
Minocycline—CYCS—Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.—SDHD—leprosy	0.00331	0.0114	CbGpPWpGaD
Minocycline—CYCS—Sulfathiazole—Dapsone—leprosy	0.00308	0.344	CbGdCrCtD
Minocycline—CASP3—FAS pathway and Stress induction of HSP regulation—RIPK2—leprosy	0.00307	0.0106	CbGpPWpGaD
Minocycline—IL1B—Cytokines and Inflammatory Response—IL10—leprosy	0.00303	0.0105	CbGpPWpGaD
Minocycline—IL1B—skin of body—leprosy	0.00301	0.0144	CbGeAlD
Minocycline—IL1B—Interleukin-1 signaling—RIPK2—leprosy	0.00289	0.00999	CbGpPWpGaD
Minocycline—MMP9—eye—leprosy	0.00288	0.0138	CbGeAlD
Minocycline—CASP1—testis—leprosy	0.00288	0.0138	CbGeAlD
Minocycline—CASP3—tendon—leprosy	0.00287	0.0137	CbGeAlD
Minocycline—IL1B—NOD pathway—RIPK2—leprosy	0.00283	0.0098	CbGpPWpGaD
Minocycline—CASP1—nervous system—leprosy	0.00282	0.0136	CbGeAlD
Minocycline—CYCS—testis—leprosy	0.00277	0.0133	CbGeAlD
Minocycline—CYCS—nervous system—leprosy	0.00272	0.013	CbGeAlD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—TLR1—leprosy	0.00268	0.00928	CbGpPWpGaD
Minocycline—IL1B—Interleukin-1 signaling—NOD2—leprosy	0.00262	0.00906	CbGpPWpGaD
Minocycline—IL1B—NOD pathway—NOD2—leprosy	0.00257	0.00888	CbGpPWpGaD
Minocycline—CYCS—p75(NTR)-mediated signaling—RIPK2—leprosy	0.00255	0.00884	CbGpPWpGaD
Minocycline—CYCS—The citric acid (TCA) cycle and respiratory electron transport—SDHD—leprosy	0.00255	0.00881	CbGpPWpGaD
Minocycline—MMP9—skin of body—leprosy	0.00251	0.012	CbGeAlD
Minocycline—IL1B—Cytokines and Inflammatory Response—HLA-DRB1—leprosy	0.00244	0.00844	CbGpPWpGaD
Minocycline—CASP3—testis—leprosy	0.00237	0.0114	CbGeAlD
Minocycline—CASP3—nervous system—leprosy	0.00233	0.0112	CbGeAlD
Minocycline—IL1B—tendon—leprosy	0.00229	0.011	CbGeAlD
Minocycline—VEGFA—tendon—leprosy	0.00225	0.0108	CbGeAlD
Minocycline—CASP1—Cellular roles of Anthrax toxin—TNF—leprosy	0.00217	0.00752	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—TLR1—leprosy	0.00209	0.00724	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—RIPK2—leprosy	0.00209	0.00722	CbGpPWpGaD
Minocycline—CASP1—Signaling by Interleukins—RIPK2—leprosy	0.00209	0.00722	CbGpPWpGaD
Minocycline—CASP3—p75(NTR)-mediated signaling—RIPK2—leprosy	0.00206	0.00714	CbGpPWpGaD
Minocycline—CASP3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—leprosy	0.00204	0.00708	CbGpPWpGaD
Minocycline—CASP1—IFN-gamma pathway—IFNG—leprosy	0.00196	0.0068	CbGpPWpGaD
Minocycline—IL1B—IL1 and megakaryotyces in obesity—IFNG—leprosy	0.00196	0.00678	CbGpPWpGaD
Minocycline—MMP9—tendon—leprosy	0.00191	0.00915	CbGeAlD
Minocycline—IL1B—testis—leprosy	0.0019	0.0091	CbGeAlD
Minocycline—CASP1—Signaling by Interleukins—NOD2—leprosy	0.00189	0.00655	CbGpPWpGaD
Minocycline—VEGFA—testis—leprosy	0.00186	0.00895	CbGeAlD
Minocycline—IL1B—nervous system—leprosy	0.00186	0.00893	CbGeAlD
Minocycline—IL1B—IL27-mediated signaling events—IFNG—leprosy	0.00184	0.00636	CbGpPWpGaD
Minocycline—CASP3—p75 NTR receptor-mediated signalling—RIPK2—leprosy	0.0018	0.00622	CbGpPWpGaD
Minocycline—IL1B—Cytokines and Inflammatory Response—IFNG—leprosy	0.00178	0.00617	CbGpPWpGaD
Minocycline—IL1B—Cytokines and Inflammatory Response—CD4—leprosy	0.00172	0.00596	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—CYLD—leprosy	0.00165	0.00572	CbGpPWpGaD
Minocycline—IL1B—IL27-mediated signaling events—IL2—leprosy	0.00163	0.00565	CbGpPWpGaD
Minocycline—IL1B—Cytokines and Inflammatory Response—IL2—leprosy	0.00158	0.00548	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—CD8A—leprosy	0.00158	0.00547	CbGpPWpGaD
Minocycline—MMP9—testis—leprosy	0.00158	0.00758	CbGeAlD
Minocycline—MMP9—nervous system—leprosy	0.00155	0.00744	CbGeAlD
Minocycline—SLC22A8—eye—leprosy	0.00154	0.00739	CbGeAlD
Minocycline—IL1B—TCR Signaling Pathway—RIPK2—leprosy	0.00151	0.00522	CbGpPWpGaD
Minocycline—VEGFA—Hypertrophy Model—IFNG—leprosy	0.00151	0.00522	CbGpPWpGaD
Minocycline—MMP9—IL1 and megakaryotyces in obesity—IFNG—leprosy	0.0015	0.0052	CbGpPWpGaD
Minocycline—SLC22A7—testis—leprosy	0.00146	0.00701	CbGeAlD
Minocycline—CASP3—Allograft Rejection—CD40LG—leprosy	0.00142	0.00491	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—IL10—leprosy	0.00142	0.00491	CbGpPWpGaD
Minocycline—CASP1—Amyotrophic lateral sclerosis (ALS)—TNF—leprosy	0.0014	0.00486	CbGpPWpGaD
Minocycline—IL1B—Type II interferon signaling (IFNG)—IFNG—leprosy	0.00138	0.00479	CbGpPWpGaD
Minocycline—IL1B—IL23-mediated signaling events—IFNG—leprosy	0.00138	0.00479	CbGpPWpGaD
Minocycline—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	0.00138	0.00479	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—TLR2—leprosy	0.00136	0.00472	CbGpPWpGaD
Minocycline—IL1B—Cellular roles of Anthrax toxin—TNF—leprosy	0.00136	0.0047	CbGpPWpGaD
Minocycline—CYCS—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—leprosy	0.00134	0.00465	CbGpPWpGaD
Minocycline—IL1B—IL23-mediated signaling events—CD4—leprosy	0.00134	0.00463	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—RIPK2—leprosy	0.0013	0.00451	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—HLA-DRB1—leprosy	0.00129	0.00446	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—IL10—leprosy	0.00128	0.00444	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—CD40LG—leprosy	0.00128	0.00444	CbGpPWpGaD
Minocycline—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	0.00126	0.00435	CbGpPWpGaD
Minocycline—ALOX5—testis—leprosy	0.00125	0.00599	CbGeAlD
Minocycline—IL1B—IL23-mediated signaling events—IL2—leprosy	0.00123	0.00426	CbGpPWpGaD
Minocycline—IL1B—IFN-gamma pathway—IFNG—leprosy	0.00123	0.00425	CbGpPWpGaD
Minocycline—ALOX5—nervous system—leprosy	0.00123	0.00588	CbGeAlD
Minocycline—CASP3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—leprosy	0.0012	0.00416	CbGpPWpGaD
Minocycline—IL1B—IL27-mediated signaling events—TNF—leprosy	0.00119	0.00411	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—NOD2—leprosy	0.00118	0.00409	CbGpPWpGaD
Minocycline—IL1B—Aryl Hydrocarbon Receptor Pathway—IFNG—leprosy	0.00116	0.00403	CbGpPWpGaD
Minocycline—IL1B—Cytokines and Inflammatory Response—TNF—leprosy	0.00115	0.00399	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—CD8A—leprosy	0.00114	0.00396	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—HLA-DRB1—leprosy	0.00114	0.00395	CbGpPWpGaD
Minocycline—CYCS—FAS pathway and Stress induction of HSP regulation—TNF—leprosy	0.00111	0.00384	CbGpPWpGaD
Minocycline—CASP3—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—leprosy	0.00108	0.00376	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—IL10—leprosy	0.00108	0.00375	CbGpPWpGaD
Minocycline—IL1B—Vitamin B12 Metabolism—IFNG—leprosy	0.00107	0.00371	CbGpPWpGaD
Minocycline—CASP3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—leprosy	0.00107	0.0037	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—TLR2—leprosy	0.00107	0.00369	CbGpPWpGaD
Minocycline—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	0.00106	0.00365	CbGpPWpGaD
Minocycline—IL1B—Aryl Hydrocarbon Receptor Pathway—IL2—leprosy	0.00103	0.00358	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—HLA-DRB1—leprosy	0.00103	0.00358	CbGpPWpGaD
Minocycline—IL1B—Monoamine Transport—TNF—leprosy	0.00101	0.00348	CbGpPWpGaD
Minocycline—CYCS—Ceramide signaling pathway—TNF—leprosy	0.000996	0.00345	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—RIPK2—leprosy	0.000974	0.00337	CbGpPWpGaD
Minocycline—CASP3—Amyotrophic lateral sclerosis (ALS)—TNF—leprosy	0.000969	0.00335	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—IFNG—leprosy	0.00094	0.00326	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—CD4—leprosy	0.000908	0.00314	CbGpPWpGaD
Minocycline—IL1B—IL23-mediated signaling events—TNF—leprosy	0.000896	0.0031	CbGpPWpGaD
Minocycline—CASP3—FAS pathway and Stress induction of HSP regulation—TNF—leprosy	0.000895	0.0031	CbGpPWpGaD
Minocycline—CASP3—TWEAK Signaling Pathway—TNF—leprosy	0.000895	0.0031	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—NOD2—leprosy	0.000883	0.00306	CbGpPWpGaD
Minocycline—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	0.000881	0.00305	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—IFNG—leprosy	0.000871	0.00302	CbGpPWpGaD
Minocycline—CYCS—Caspase Cascade in Apoptosis—TNF—leprosy	0.000868	0.00301	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—CD40LG—leprosy	0.000854	0.00296	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IL10—leprosy	0.000854	0.00296	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CYLD—leprosy	0.000847	0.00293	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—IL2—leprosy	0.000836	0.00289	CbGpPWpGaD
Minocycline—CASP1—Signaling by Interleukins—IL2—leprosy	0.000835	0.00289	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—IFNG—leprosy	0.000834	0.00289	CbGpPWpGaD
Minocycline—SLC22A8—nervous system—leprosy	0.000829	0.00398	CbGeAlD
Minocycline—CASP3—SIDS Susceptibility Pathways—IL10—leprosy	0.000823	0.00285	CbGpPWpGaD
Minocycline—MMP9—Matrix Metalloproteinases—TNF—leprosy	0.000813	0.00281	CbGpPWpGaD
Minocycline—CASP3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—leprosy	0.000778	0.00269	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—IL2—leprosy	0.000774	0.00268	CbGpPWpGaD
Minocycline—MMP9—amb2 Integrin signaling—TNF—leprosy	0.000772	0.00267	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—IFNG—leprosy	0.000755	0.00261	CbGpPWpGaD
Minocycline—MMP9—CXCR4-mediated signaling events—HLA-DRB1—leprosy	0.000755	0.00261	CbGpPWpGaD
Minocycline—IL1B—Aryl Hydrocarbon Receptor Pathway—TNF—leprosy	0.000753	0.00261	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—IL10—leprosy	0.000745	0.00258	CbGpPWpGaD
Minocycline—CASP1—Apoptosis—TNF—leprosy	0.000744	0.00258	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—IL2—leprosy	0.000741	0.00256	CbGpPWpGaD
Minocycline—CASP3—Caspase Cascade in Apoptosis—TNF—leprosy	0.000701	0.00243	CbGpPWpGaD
Minocycline—IL1B—Vitamin B12 Metabolism—TNF—leprosy	0.000693	0.0024	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—IFNG—leprosy	0.000692	0.0024	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—HLA-DRB1—leprosy	0.000688	0.00238	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—IL2—leprosy	0.000671	0.00232	CbGpPWpGaD
Minocycline—CYCS—Alzheimers Disease—TNF—leprosy	0.000669	0.00232	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—RIPK2—leprosy	0.000661	0.00229	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—CD4—leprosy	0.000657	0.00227	CbGpPWpGaD
Minocycline—CASP3—Corticotropin-releasing hormone—IL2—leprosy	0.000656	0.00227	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—IFNG—leprosy	0.000643	0.00223	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—IFNG—leprosy	0.000638	0.00221	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TNF—leprosy	0.000637	0.0022	CbGpPWpGaD
Minocycline—SLC22A11—SLC-mediated transmembrane transport—SLC11A1—leprosy	0.000629	0.00218	CbGpPWpGaD
Minocycline—MMP9—TWEAK Signaling Pathway—TNF—leprosy	0.000621	0.00215	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—SLC11A1—leprosy	0.000616	0.00213	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—RIPK2—leprosy	0.000608	0.00211	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—IFNG—leprosy	0.000605	0.00209	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—IFNG—leprosy	0.000601	0.00208	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—HLA-DRB1—leprosy	0.000601	0.00208	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—IFNG—leprosy	0.000584	0.00202	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—IL2—leprosy	0.000572	0.00198	CbGpPWpGaD
Minocycline—SLC22A7—SLC-mediated transmembrane transport—SLC11A1—leprosy	0.000571	0.00198	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—IL2—leprosy	0.000567	0.00196	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—TNF—leprosy	0.000564	0.00195	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—NOD2—leprosy	0.000552	0.00191	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—IFNG—leprosy	0.000547	0.0019	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—RIPK2—leprosy	0.000546	0.00189	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—TLR2—leprosy	0.000546	0.00189	CbGpPWpGaD
Minocycline—CASP3—Alzheimers Disease—TNF—leprosy	0.00054	0.00187	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—TNF—leprosy	0.00054	0.00187	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—IL2—leprosy	0.000537	0.00186	CbGpPWpGaD
Minocycline—MMP9—CXCR4-mediated signaling events—CD4—leprosy	0.000532	0.00184	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—IL2—leprosy	0.000522	0.00181	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TNF—leprosy	0.000514	0.00178	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IFNG—leprosy	0.000502	0.00174	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—TNF—leprosy	0.000501	0.00174	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL10—leprosy	0.000496	0.00172	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—NOD2—leprosy	0.000495	0.00171	CbGpPWpGaD
Minocycline—CASP1—Immune System—CYLD—leprosy	0.000493	0.00171	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—TNF—leprosy	0.000488	0.00169	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—TNF—leprosy	0.000488	0.00169	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—IL2—leprosy	0.000486	0.00168	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—leprosy	0.00048	0.00166	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—TNF—leprosy	0.000478	0.00165	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—TNF—leprosy	0.000448	0.00155	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IL2—leprosy	0.000446	0.00155	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IFNG—leprosy	0.000439	0.00152	CbGpPWpGaD
Minocycline—CASP1—Immune System—PARK2—leprosy	0.000436	0.00151	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TNF—leprosy	0.000427	0.00148	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IFNG—leprosy	0.00042	0.00145	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—leprosy	0.0004	0.00139	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—TNF—leprosy	0.000398	0.00138	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TNF—leprosy	0.000391	0.00136	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TNF—leprosy	0.00039	0.00135	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IL2—leprosy	0.00039	0.00135	CbGpPWpGaD
Minocycline—CYCS—Metabolism—SDHD—leprosy	0.000384	0.00133	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—TNF—leprosy	0.000378	0.00131	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HLA-DRB1—leprosy	0.000375	0.0013	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL2—leprosy	0.000373	0.00129	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TNF—leprosy	0.000354	0.00123	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—TNF—leprosy	0.000325	0.00113	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—SLC11A1—leprosy	0.00032	0.00111	CbGpPWpGaD
Minocycline—CASP1—Immune System—RIPK2—leprosy	0.000318	0.0011	CbGpPWpGaD
Minocycline—CASP1—Immune System—TLR2—leprosy	0.000318	0.0011	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TNF—leprosy	0.000315	0.00109	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—TNF—leprosy	0.000313	0.00108	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—TNF—leprosy	0.000311	0.00108	CbGpPWpGaD
Minocycline—IL1B—Immune System—CYLD—leprosy	0.000308	0.00107	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TNF—leprosy	0.000295	0.00102	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—SLC11A1—leprosy	0.00029	0.001	CbGpPWpGaD
Minocycline—CASP1—Immune System—NOD2—leprosy	0.000288	0.000998	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—TNF—leprosy	0.000283	0.000981	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IFNG—leprosy	0.000274	0.000949	CbGpPWpGaD
Minocycline—IL1B—Immune System—PARK2—leprosy	0.000273	0.000944	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TNF—leprosy	0.000272	0.000941	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TNF—leprosy	0.000267	0.000925	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TNF—leprosy	0.000266	0.000922	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC11A1—leprosy	0.000244	0.000844	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD40LG—leprosy	0.000244	0.000844	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL2—leprosy	0.000244	0.000844	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD8A—leprosy	0.000241	0.000834	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CD4—leprosy	0.000238	0.000823	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—SDHD—leprosy	0.000237	0.000819	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC11A1—leprosy	0.000203	0.000704	CbGpPWpGaD
Minocycline—IL1B—Immune System—RIPK2—leprosy	0.000199	0.000688	CbGpPWpGaD
Minocycline—IL1B—Immune System—TLR2—leprosy	0.000199	0.000688	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-DRB1—leprosy	0.000196	0.000679	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—IL2—leprosy	0.000196	0.000679	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—TNF—leprosy	0.000189	0.000653	CbGpPWpGaD
Minocycline—IL1B—Immune System—NOD2—leprosy	0.00018	0.000624	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—leprosy	0.00016	0.000556	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD40LG—leprosy	0.000152	0.000527	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD8A—leprosy	0.000151	0.000521	CbGpPWpGaD
Minocycline—CASP1—Immune System—IFNG—leprosy	0.000143	0.000496	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RIPK2—leprosy	0.000142	0.000491	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD4—leprosy	0.000138	0.000479	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL2—leprosy	0.000127	0.000441	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-DRB1—leprosy	0.000123	0.000425	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IL2—leprosy	0.000101	0.00035	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RIPK2—leprosy	9.85e-05	0.000341	CbGpPWpGaD
Minocycline—IL1B—Immune System—IFNG—leprosy	8.96e-05	0.00031	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD4—leprosy	8.65e-05	0.000299	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TNF—leprosy	8.64e-05	0.000299	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RIPK2—leprosy	8.55e-05	0.000296	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL2—leprosy	7.96e-05	0.000276	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TNF—leprosy	7.5e-05	0.00026	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL2—leprosy	5.69e-05	0.000197	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL2—leprosy	3.95e-05	0.000137	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL2—leprosy	3.43e-05	0.000119	CbGpPWpGaD
